香蕉久久久 I 国产777 I 中文人妻av大区中文不卡 I 久久综合伊人77777蜜臀 I 婷婷视频导航 I 天天综合永久 I 国产性生交xxxxx免费 I 中文字幕人妻无码视频 I 99精彩视频在线观看 I 久久久久久久久久成人 I 久久精品免视看国产成人2021 I 国产精品精 I 日本又色又爽又黄又高潮 I 国产精选在线播放 I 奇米色7777 I 特级a做爰全过程片 I 激情五月综合五月 I 久久久久久激情 I 在线香蕉视频 I 中文字幕有码av I 色成人 I 日本人zzzwww色视频看看 I 被窝福利片久久福利片 I 色欧美乱欧美乱妇15图片 I 97中文字幕第三 I 成人影院yy111111 I 少妇饥渴xxhd麻豆xxhd骆驼 I 91麻豆精品国产91久久久无需广告 I 国产色在线视频 I 亚洲黄色精品视频 I 免费毛片18女人毛片大全在线看 I 91精品国产日韩一区二区三区 I 亚洲美女视频网

一.產品名稱：

通用名稱：大/小鼠成纖維細胞生長因子23 ELISA試劑盒

英文名稱：Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介紹：

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.
 

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.

Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.

Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.
 

如需了解更多產品，請北京科瑞美公司。